{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T05:31:19Z","timestamp":1732167079132,"version":"3.28.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,20]]},"DOI":"10.7759\/cureus.74091","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T16:16:09Z","timestamp":1732119369000},"source":"Crossref","is-referenced-by-count":0,"title":["Porphyria Cutanea Tarda in a Patient With Hereditary Hemochromatosis: A Complex Overlap Disorder"],"prefix":"10.7759","author":[{"given":"Bethani L","family":"DeMaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron J","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000173696","article-title":"Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study","volume":"218","author":"Cribier B","year":"2009","unstructured":"Cribier B, Chiaverini C, Dali-Youcef N, et al.. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study. Dermatology. 2009, 218:15-21. 10.1159\/000173696","journal-title":"Dermatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1565.005k42_1565_1571","article-title":"Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda","volume":"95","author":"Bulaj ZJ","year":"2000","unstructured":"Bulaj ZJ, Phillips JD, Ajioka RS, et al.. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood. 2000, 95:1565-71. 10.1182\/blood.V95.5.1565.005k42_1565_1571","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61782-6","article-title":"Haemochromatosis","volume":"370","author":"Adams PC","year":"2007","unstructured":"Adams PC, Barton JC. Haemochromatosis. Lancet. 2007, 370:1855-60. 10.1016\/s0140-6736(07)61782-6","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-138222","article-title":"Down-regulation of hepcidin in porphyria cutanea tarda","volume":"112","author":"Ajioka RS","year":"2008","unstructured":"Ajioka RS, Phillips JD, Weiss RB, et al.. Down-regulation of hepcidin in porphyria cutanea tarda. Blood. 2008, 112:4723-8. 10.1182\/blood-2008-02-138222","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12090819","article-title":"Iron metabolism in the disorders of heme biosynthesis","volume":"12","author":"Ricci A","year":"2022","unstructured":"Ricci A, Di Betto G, Bergamini E, Buzzetti E, Corradini E, Ventura P. Iron metabolism in the disorders of heme biosynthesis. Metabolites. 2022, 12:819. 10.3390\/metabo12090819","journal-title":"Metabolites"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ph11040137","article-title":"Iron regulation: macrophages in control","volume":"11","author":"Sukhbaatar N","year":"2018","unstructured":"Sukhbaatar N, Weichhart T. Iron regulation: macrophages in control. Pharmaceuticals (Basel). 2018, 11:137. 10.3390\/ph11040137","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref7","article-title":"Iron overload in porphyria cutanea tarda","volume":"84","author":"Sampietro M","year":"1999","unstructured":"Sampietro M, Fiorelli G, Fargion S. Iron overload in porphyria cutanea tarda. Haematologica. 1999, 84:248-53.","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1436897","article-title":"Heme (dys)homeostasis and liver disease","volume":"15","author":"Duarte TL","year":"2024","unstructured":"Duarte TL, Viveiros N, Godinho C, Duarte D. Heme (dys)homeostasis and liver disease. Front Physiol. 2024, 15:1436897. 10.3389\/fphys.2024.1436897","journal-title":"Front Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.037","article-title":"Mechanisms of iron hepatotoxicity","volume":"65","author":"Pietrangelo A","year":"2016","unstructured":"Pietrangelo A. Mechanisms of iron hepatotoxicity. J Hepatol. 2016, 65:226-7. 10.1016\/j.jhep.2016.01.037","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-016-0698-0","article-title":"Hepatic porphyria: a narrative review","volume":"35","author":"Arora S","year":"2016","unstructured":"Arora S, Young S, Kodali S, Singal AK. Hepatic porphyria: a narrative review. Indian J Gastroenterol. 2016, 35:405-18. 10.1007\/s12664-016-0698-0","journal-title":"Indian J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.04.008","article-title":"Heme biosynthesis and the porphyrias","volume":"128","author":"Phillips JD","year":"2019","unstructured":"Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab. 2019, 128:164-77. 10.1016\/j.ymgme.2019.04.008","journal-title":"Mol Genet Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000247","article-title":"Sporadic porphyria cutanea tarda as the initial manifestation of hereditary hemochromatosis","volume":"6","author":"Edwards MV","year":"2019","unstructured":"Edwards MV, Ray JM, Bacon BR. Sporadic porphyria cutanea tarda as the initial manifestation of hereditary hemochromatosis. ACG Case Rep J. 2019, 6:e00247. 10.14309\/crj.0000000000000247","journal-title":"ACG Case Rep J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700547104","article-title":"A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips JD","year":"2007","unstructured":"Phillips JD, Bergonia HA, Reilly CA, Franklin MR, Kushner JP. A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proc Natl Acad Sci U S A. 2007, 104:5079-84. 10.1073\/pnas.0700547104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1968.tb02443.x","article-title":"Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda","volume":"184","author":"Lundvall O","year":"1968","unstructured":"Lundvall O, Weinfeld A. Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda. Acta Med Scand. 1968, 184:191-9. 10.1111\/j.0954-6820.1968.tb02443.x","journal-title":"Acta Med Scand"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21885","article-title":"Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls","volume":"46","author":"Ellervik C","year":"2007","unstructured":"Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology. 2007, 46:1071-80. 10.1002\/hep.21885","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.372","article-title":"Coordination of iron homeostasis by bone morphogenetic proteins: current understanding and unanswered questions","volume":"251","author":"Fisher AL","year":"2022","unstructured":"Fisher AL, Babitt JL. Coordination of iron homeostasis by bone morphogenetic proteins: current understanding and unanswered questions. Dev Dyn. 2022, 251:26-46. 10.1002\/dvdy.372","journal-title":"Dev Dyn"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.07.082","article-title":"Increased mortality in patients with porphyria cutanea tarda-a nationwide cohort study","volume":"83","author":"Christiansen AL","year":"2020","unstructured":"Christiansen AL, Brock A, Bygum A, Rasmussen LM, Jepsen P. Increased mortality in patients with porphyria cutanea tarda-a nationwide cohort study. J Am Acad Dermatol. 2020, 83:817-23. 10.1016\/j.jaad.2019.07.082","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-253203","article-title":"Porphyria cutanea tarda: an under-recognised manifestation of haemochromatosis","volume":"16","author":"Goh JW","year":"2023","unstructured":"Goh JW, Ong CK, Abdullah KM. Porphyria cutanea tarda: an under-recognised manifestation of haemochromatosis. BMJ Case Rep. 2023, 16:e253203. 10.1136\/bcr-2022-253203","journal-title":"BMJ Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280482-porphyria-cutanea-tarda-in-a-patient-with-hereditary-hemochromatosis-a-complex-overlap-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T16:16:10Z","timestamp":1732119370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280482-porphyria-cutanea-tarda-in-a-patient-with-hereditary-hemochromatosis-a-complex-overlap-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.74091","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}